In February, CEO Update named National Association of Chain Drug Stores president and CEO Steve Anderson Trade Association CEO of the Year. DSN looks at some of the more important work accomplished by NACDS under Anderson’s leadership.
The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.
The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs.
The complaint alleges that Endo paid Impax Laboratories and Watson Laboratories, which were the first companies to file for FDA approval for generics of Endo’s Opana ER and Lidoderm, to delay their generic product launches.